Phathom Pharmaceuticals, Inc. (PHAT)
NASDAQ: PHAT · IEX Real-Time Price · USD
11.74
+0.46 (4.08%)
At close: Jul 26, 2024, 4:00 PM
11.54
-0.20 (-1.70%)
After-hours: Jul 26, 2024, 6:35 PM EDT

Phathom Pharmaceuticals Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year Ending
TTM Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019 2018
Revenue
2.590.68----
Upgrade
Cost of Revenue
0.590.17----
Upgrade
Gross Profit
20.52----
Upgrade
Selling, General & Admin
161.34117.9310162.7427.526.94
Upgrade
Research & Development
47.8549.971.4472.3498.1520.37
Upgrade
Operating Expenses
209.19167.83172.44135.08125.6727.32
Upgrade
Operating Income
-207.19-167.31-172.44-135.08-125.67-27.32
Upgrade
Interest Expense
-49.92-41.97-27.31-6.79-4.58-4.18
Upgrade
Interest & Investment Income
10.737.882.130.041.091.09
Upgrade
Other Non Operating Income (Expenses)
-0.25-0.19-0.11-0.060.09-96.28
Upgrade
EBT Excluding Unusual Items
-246.63-201.59-197.72-141.88-129.07-126.69
Upgrade
Other Unusual Items
----2--49.55
Upgrade
Pretax Income
-246.63-201.59-197.72-143.88-129.07-255.13
Upgrade
Net Income
-246.63-201.59-197.72-143.88-129.07-255.13
Upgrade
Net Income to Common
-246.63-201.59-197.72-143.88-129.07-255.13
Upgrade
Shares Outstanding (Basic)
555139373311
Upgrade
Shares Outstanding (Diluted)
555139373311
Upgrade
Shares Change (YoY)
37.55%31.11%5.72%11.36%192.32%87.83%
Upgrade
EPS (Basic)
-4.46-3.93-5.05-3.89-3.88-22.45
Upgrade
EPS (Diluted)
-4.46-3.93-5.05-3.89-3.88-22.45
Upgrade
Free Cash Flow
-168.39-139.21-147.57-148.79-70.73-36.64
Upgrade
Free Cash Flow Per Share
-3.05-2.71-3.77-4.02-2.13-3.22
Upgrade
Gross Margin
77.14%75.51%----
Upgrade
Operating Margin
-7987.24%-24532.55%----
Upgrade
Free Cash Flow Margin
-6491.56%-20412.61%----
Upgrade
EBITDA
-206.55-166.74-171.82-134.56-125.34-27.31
Upgrade
D&A For EBITDA
0.640.580.620.520.320.01
Upgrade
EBIT
-207.19-167.31-172.44-135.08-125.67-27.32
Upgrade
Source: S&P Capital IQ. Standard template.